🔎 Trials Near Me

Hjem › Overvægt › Texas › Austin

Overvægt kliniske forsøg i Austin, TX

18 studier for Overvægt søger deltagere på steder i og omkring Austin (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

RekruttererFase 2
  • Elligo Clinical Research Center /ID# 282166, Austin
Alder 18 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT07752979

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

RekruttererFase 3
  • Texas Diabetes & Endocrinology, Austin
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

RekruttererFase 3
  • IMA Clinical Research Austin, Austin
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07794579

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

RekruttererFase 3
  • Dell Children's Medical Center - PIN, Austin
Alder 6 til 17 · Alle køn · Opdateret 24. sep. 2026 · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

RekruttererFase 3
  • IMA Clinical Research Austin, Austin
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

RekruttererFase 3
  • FutureSearch Trials of Neurology, Austin
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

RekruttererFase 3
  • Austin Heart, Austin
  • Velocity Clinical Research - Austin, Austin
Alder 45 til 99 · Alle køn · Opdateret 22. sep. 2026 · NCT07037433

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

RekruttererFase 2
  • IMA Clinical Research Austin, Austin
Alder 18 til 75 · Alle køn · Opdateret 22. sep. 2026 · NCT07589608

Semaglutide for Post-Smoking Cessation Weight Management

RekruttererFase 2Frivillige med god helbredstilstand velkomne
  • The University of Texas at Austin, Austin
Alder 18 til 75 · Alle køn · Opdateret 21. sep. 2026 · NCT06173778

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

RekruttererFase 3
  • AURORA-1 Clinical Site, Austin
Alder 18 og opefter · Alle køn · Opdateret 16. sep. 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

RekruttererFase 3
  • AURORA-2 Clinical Site, Austin
Alder 18 og opefter · Alle køn · Opdateret 16. sep. 2026 · NCT07743450

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

RekruttererFase 3Frivillige med god helbredstilstand velkomne
  • ACCOMPLISH-2 Research Site, Austin
Alder 18 til 79 · Alle køn · Opdateret 11. sep. 2026 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

RekruttererFase 2
  • IMA Clinical Research Austin, Austin
Alder 18 til 75 · Alle køn · Opdateret 8. sep. 2026 · NCT06143956

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

RekruttererFase 3
  • Elligo Clinical Research Center, Austin
Alder 18 til 99 · Alle køn · Opdateret 3. sep. 2026 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

RekruttererFase 3
  • Elligo Clinical Research Center, Austin
Alder 18 til 99 · Alle køn · Opdateret 3. sep. 2026 · NCT07684144

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

RekruttererFase 3
  • ACCOMPLISH-1 Research Site, Austin
  • ACCOMPLISH-1 Research Site, Austin
Alder 18 til 79 · Alle køn · Opdateret 10. aug. 2026 · NCT07654361

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

RekruttererFase 1
  • Elligo Clin Res Centre, Austin
Alder 18 og opefter · Alle køn · Opdateret 25. jun. 2026 · NCT07607587

A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets

RekruttererFase 1
  • Corxel Investigational Site, Austin
Alder 18 til 55 · Kvinder · Opdateret 17. jun. 2026 · NCT07652047

Overvægt forsøg i andre byer

Andre studier i Austin

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.